5th Annual Pharmaceutical and Biotech Medical Affairs Pre-Launch Strategies Conference

As the pharmaceutical industry trends towards earlier and more frequent involvement of medical affairs teams in pre-launch activities, common standards and strategies to reach excellence are being redefined. Medical affairs professionals face evolving challenges in designing blueprints for proactive engagement with internal corporate departments and external stakeholders in order to successfully drive product value and awareness in relevant scientific community and payer healthcare networks.

Forward-thinking executives embrace the opportunity to employ innovative strategies in cross-functional alignment and organizational tactics to enhance operational efficacy from Phase I to launch day. Furthermore, with the importance of crafting the most accurate scientific narrative, professionals aim to continuously define and ultimately ensure generation of real-world evidence in relation to the targeted market to shed light on product value in an enhanced manner.

The 5th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference will virtually connect medical affairs teams across a range of therapeutic areas in the following modules:

Module 1: Enhancing the Corporate Structure to Facilitate Efficient Execution Of Pre-launch Goals
Module 2: Crafting Evidence-Based Strategies For Pre-Launch Success
Module 3: Optimizing Timelines for Key Pre-launch Operations to Successfully Achieve Goals

Join us to for open dialogue, collaboration, and benchmarking against best industry practices in a selective and small-group format. Individual modules are available for $595. The entire course may be accessed for $1,500.